THE VOGEL GROUP

Lobbying for AVARA PHARMACEUTICALS INC. · Generic Pharmaceutical Manufacturing Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Oklahoma · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to business operations in Oklahoma; Issues related to financial services

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.